319 results on '"Ala, Aftab"'
Search Results
2. Exploring awareness and prevalence of chronic viral hepatitis in a UK based Nepali population – lessons learned for future models in engaging migrant communities
3. Wrought Iron Thresholds: How Magnetic Resonance Liver Iron Concentration Can Guide Decision-Making in Hyperferritinemic Patients
4. Neurological worsening in Wilson disease – clinical classification and outcome
5. Guideline Review: European Association for the Study of Liver (EASL) Clinical Practice Guidelines on Haemochromatosis
6. Wilson disease
7. ATP7B Genotype and Chronic Liver Disease Treatment Outcomes in Wilson Disease: Worse Survival With Loss-of-Function Variants
8. Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated
9. Major Depressive Disorder in an International Multisite Wilson Disease Registry
10. WED-137-YI Reviewing the largest experience of liver transplantation for Wilson’s disease in the UK: single centre review of patient and graft outcomes and long term survival
11. WED-164 Interim safety results of the ongoing international phase I/II GATEWAY gene therapy trial with VTX-801 conducted in adult patients with Wilson disease
12. WED-192 Raising awareness of long term chelation therapy challenges in Wilson’s disease-Potential implications of monitoring and developing skin and vascular complications
13. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
14. Investigation and management of Wilson's disease: a practical guide from the British Association for the Study of the Liver
15. Effect of oral zinc regimens on human hepatic copper content: a randomized intervention study
16. Transforming global hepatology training: a call for action
17. Skin changes in long-term Wilson's disease
18. The Effect of Mental Health, Neurological Disease, and Liver Disease on Quality of Life in Patients With Wilson Disease
19. Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants in community and faith settings using educational interventions—A prospective descriptive study
20. The Epidemiology of Rare Hereditary Metabolic Liver Diseases
21. A Snapshot of Digital Transformation in Hepatology and Rare Liver Disease Related Health Care: A UK Perspective
22. Reply to: “Early neurological worsening in Wilson disease: The need for an evidence-based definition”
23. Clinical Ontologies Improve Case Finding of Primary Biliary Cholangitis in UK Primary and Secondary Care
24. Feeling misidentified: Understanding migrant's readiness to engage in health care screening
25. P24 A review of Wilson’s disease explant histology as a basis for future histopathology consortia – Preliminary findings from the largest UK cohort of patients
26. P21 Monitoring maintenance therapy with D-Penicillamine for Wilson’s Disease: lessons from screening for a randomized trial
27. P20 Patterns of ALT, AST and 24-hour urine copper in adult patients with treated Wilson disease: results from an international multi-site registry at enrolment and over the course of 3 years
28. P25 Quality of life in patients with Wilson disease treated with Trientine dihydrochloride: a prospective study
29. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
30. Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study
31. The UK research ethics committee: Making the case for better serving the underserved – can we do better?
32. Histology – further raising the diagnostic bar in chronic liver disease
33. Novel intervention to promote COVID-19 protective behaviours among Black and South Asian communities in the UK: protocol for a mixed-methods pilot evaluation
34. Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency
35. Liver disease
36. Wilson's Disease
37. The Diagnostic Approach to Wilson Disease
38. Contributors
39. The Epidemiology of Rare Hereditary Metabolic Liver Diseases
40. Wilson's disease
41. Wilson Disease
42. Removing PEG tubes with ‘buried bumpers’: Lessons learnt from four patients
43. Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial
44. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
45. Unpacking COVID ‐19 and conspiracy theories in the UK black community
46. P02 Development and validation of a Novel ICP-MS method to quantify different copper species in human plasma from patients with wilson disease
47. P08 Genetic variability in Wilson’s disease- real world results from London, UK
48. OP32 Modernising Hepatology training: An international comparison of the current and new 2022 UK Hepatology curriculum
49. O01 Efficacy and safety of ALXN1840 versus standard of care in Wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial
50. Frameworks for Implementation, Uptake, and Use of Cardiometabolic Disease–Related Digital Health Interventions in Ethnic Minority Populations: Scoping Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.